投融资数据库
免费查数据
注册送3天会员
首页>投融资
Becton Dickinson
收并购
Becton, Dickinson and Co is a medical technology company with a particular emphasis on diagnostics and disposables.In July 2022, Becton, Dickinson and Co acquired MedKeeper.In April 2022, Becton, Dickinson and Co had completed its spinoff of Embecta Corp.In February 2022, Becton, Dickinson and Co had announced the sale of Cytognos by Vitro SA. Later that month, the company acquired Cytognos Sl completely.In December 2021, the company had acquired Tissuemed Ltd. Later that month, the company announced it completed the acquisition of Scanwell Health Inc.In November 2020, BD had acquired the medical business assets of CUBEX.In September 2018, Thermo Fisher Scientific had entered into a definitive agreement to acquire advanced bioprocessing business of BD Technologies.In July 2005, Becton Dickinson had agreed to sell its Clontech Laboratories Inc unit to Takara Bio for $60 million, The plan to sell Clontech had a
基本信息
-
公司全称Becton Dickinson and Co
-
类型医疗设备研发生产商、销售商
-
产业领域医疗器械
-
公司人数500人以上
-
地址One Becton Drive FRANKLIN LAKES NEW JERSEY 07417-1880; US; Telephone: +12018476800;
-
联系电话(201)847-6800
-
邮箱
-
成立时间1897-01-01
投融资
-
2024-12-02
-
2023-08-02
-
2023-08-02
-
2020-07-31
-
2016-03-08
-
2016-03-08
-
2015-01-06
-
2015-01-06
-
1963-09-25
- 加载更多
相关投融资企业
C轮
Akura Medical是Shifamed LLC的一家私人控股投资组合公司,正在开发下一代血栓切除设备,旨在通过一种易于使用的单程程序来简化血栓切除术,该程序可有效去除血栓。
收并购
Acera Surgical Inc develops and commercializes synthetic materials for regenerative medical applications
C轮
Okami Medical, Inc.是一家私有医疗器械公司,其使命是通过开发创新、多功能和直观的闭塞血管器械来满足患者和医生不断发展的需求。
目前Okami已开发出LOBO™血管闭塞系统,该系统的独特设计旨在为介入治疗的医生提供单设备,即一劳永逸的解决方案,从而无需多种栓塞设备即可阻塞多种动脉靶标。



浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息